A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- GRADE Study Group
- Study ID
- NCT01794143
- Phase
- PHASE3
- Status
- Completed
Conditions
- Comparative Effectiveness of Glycemia-lowering Medications
- Type 2 Diabetes
Eligibility Criteria
- Sex
- ALL
- Age
- 30 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Sulfonylurea (glimepiride) — DRUGUsed in accordance with labeling and/or usual practice.
- DPP-4 inhibitor (sitagliptin) — DRUGUsed in accordance with labeling and/or usual practice
- GLP-1 receptor agonist (liraglutide) — DRUGUsed in accordance with labeling and/or usual practice.
- Insulin (glargine) — DRUGUsed in accordance with labeling and/or usual practice.
Study Details
The GRADE Study is a pragmatic, unmasked clinical trial that will compare commonly used diabetes medications, when combined with metformin, on glycemia-lowering effectiveness and patient-centered outcomes.
Key Dates
- Start date
- May 31, 2013
- Status verified
- Jan 2026
- Primary completion
- Apr 30, 2021
- Completion
- Apr 30, 2021
Study Design
- Enrollment
- 7,850 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Sulfonylurea (glimepiride)Sulfonylurea
- Active Comparator: DPP-4 inhibitorDPP-4 inhibitor (sitagliptin)
- Active Comparator: GLP-1 receptor agonistGLP-1 receptor agonist (liraglutide)
- Active Comparator: Insulin (glargine)Insulin (glargine), Lantus
Primary Outcome Measure
Time to HbA1c>=7%, While Receiving Metformin and the Randomly Assigned Glucose-lowering Study Medication [ Time Frame: Quarterly for 4 to 7 years ]
Locations (36)
Related coverage on Hipa.ai
- Liraglutide Shows Longer Time to HbA1c >=7% in Type 2 Diabetes GRADE StudyLiraglutide · Feb 10, 2026 · ClinicalTrials.gov
Find similar trials in Birmingham, AL
By condition
By specialty
By research site
University of Alabama-Birmingham· Birmingham, ALSouthwestern American Indian Center· Phoenix, AZVeterans Medical Research Foundation, San Diego (San Diego VA)· San Diego, CAUniversity of Colorado· Denver, COYale University School of Medicine· New Haven, CTSouth Florida VA Foundation (Miami VA)· Miami, FL
Related Studies
- Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes PatientsPHASE1/PHASE2 · Not Yet Recruiting · ARKAY Therapeutics · Albany, New York
- The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older AdultsRecruiting · AdventHealth Translational Research Institute · Orlando, Florida
- Brown Adipose Tissue Activation by Spinal Cord StimulationRecruiting · Oregon Health and Science University · Portland, Oregon
- Mechanisms of Fatigability With DiabetesRecruiting · University of Michigan · Ann Arbor, Michigan